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Abstract 
Achyranthes aspera Linn., known as Chirchira (Hindi), Agadha 
(Marathi) is an indigenous herb found in India. It is the basic 
composition of many traditional remedies. The herb has been 
reported to have variety of activities like antifertility, 
antihyperlipidemic, antidiabetic, immunomodulatory, 
anticarcinogenic, diuretic and cardiotonic, anti-inflammatory, 
antifungal and antibacterial activity. Present study was designed to 
evaluate the antinociceptive activity of ethanolic extract of A. 
Aspera (EEAA) and to find the phytochemical responsible for this 
activity with possible mode of its activity. The antinociceptive 
activity of ethanol extract of Achyranthes aspera was investigated in 
albino mice. The pharmacological assays used were the tail flick, hot 
plate and the formalin-induced pain tests. The extract was given 
intraperitoneally at a dose of 400 mg/kg (our earlier study revealed 
no activity at the dose 200mg/kg). Pentazocine (10mg/kg body 
weight i.p.) was used as standard. Data analyzed by ANOVA test 
followed by Dunnett’s test. All the results were expressed as Mean 
(±SEM). P <0.05 was considered significant. For formalin test the 
percent inhibition was calculated by using formula (C-T)/C × 100 
(%). Phytochemical screening revealed presence of triterpenoid 
saponins possessing oleanolic acid as aglycone, viz. A & B, alkaloid 
achyranthine, water soluble base betaine and steroids. In the tail flick 
& hot plate test extract treated animals showed significant analgesic 
activity at 30, 60, 90 and 120min. Extract (400 mg/kg i.p.) reduced 
the formalin induced pain in both phases (i.e. neurogenic and 
inflammatory) by 58.8% and 92.7%, respectively. Ethanol extract of 
A.Aspera exhibit central as well as peripheral antinociceptive 
activity.  
Key words:  Achyranthes aspera   Formalin Hot plate Tail flick.
Introduction 
Nature has been a source of medicinal agents for 
thousands of years and an impressive number of 
modern drugs have been isolated from natural 
sources. India is a land of rich biodiversity; total  
 
 
number of lower and higher plants in India is 
about 45,000 species. [1]  
Achyranthes aspera  Linn. (Amaranthaceae), 
known by different names such as Chirchita 
(Hindi), Apamarga (Sanskrit), Aghedi (Gujarati), 
Apang (Bengali), Nayurivi (Tamil),Kalalat 
(Malyalam)[2] and Agadha (Marathi) in our doi:10.5138/ijpm.2010.0975.0185.02063 
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country; is a small herb found all over India 
possessing valuable medicinal properties useful 
in cough, bronchitis and rheumatism, malarial 
fever, dysentery, asthma, hypertension and 
diabetes[3, 4, 5]. In Chinese traditional medicine, 
the hot water extract of the plant has been used as 
an anti-arthritic and to alleviate arthritic pain [6]. 
 
Previous studies have reported that the herb has 
antifertility, antihyperlipidemic, immunomo-
dulatory, antidiabetic, anticarcinogenic,diuretic 
and cardiotonic [7], anti-inflammatory [8], 
antifungal [1] and antibacterial [9] activities. 
Various activities of A. aspera have been reported 
but there is hardly any report on its 
antinociceptive activity. 
 
Hence present study was designed to evaluate 
analgesic (antinociceptive) activity of an ethanol 
extract of Achyranthes aspera  (EEAA) in animal 
models for nociception. And to further evaluate 
the phytochemical responsible for this activity 
with possible mode of its action. 
 
Materials and Methods 
Present study has been conducted in the 
Department of Pharmacology at Smt. Kashibai 
Navale Medical College, Pune. The experimental 
protocol was approved by Institutional Animal 
Ethics Committee (IAEC).    
 
Plant Material 
The leaves of Achyranthes aspera  were procured 
from Empress Garden, Koregaon Park Pune and 
were identified by Botanical Survey of India 
(BSI), Pune(specimen voucher no:MRZAA1 
date:16/9/09). The leaves were washed under 
running water, shade dried and the dehydrate 
leaves powered to a fine texture and100 g of the 
dried leaves was repeatedly extracted with 95% 
ethanol for 10 days.  
 
Phytochemical study 
Freshly prepared ethanol extract of Achyranthes 
aspera  was subjected to phytochemical 
screening tests for the detection of various 
constituents using conventional protocol. [10]  
 
Experimental animals 
Wistar albino mice of either sex weighing 35-
40gms, bred in Central Animal House (CAH) 
facility of the SKN Medical College, Pune were 
used for the study. The animals were housed 
under standard laboratory conditions, maintained 
on natural light and dark cycle and had free 
access to food and water. They were acclimatized 
to laboratory conditions before the experiment. 
Each animal was used once in every experiment 
and all experiments were carried out in daylight.  
 
Acute toxicity study 
Acute toxicity study was carried out according to 
the OECD (Organization for Economic Co-
Operation and Development) Guidelines No. 423.  
 
Test methods 
Animals were divided into various groups in such 
way that 6 animals were there in each group. 
Animals treated with 5% Gum Acacia 
Suspension (0.1 ml p.o.) served as control. 
Pentazocine (10mg/kg i.p.)[11] and Aspirin 
(100mg/kg p.o.) [12] served as standards and 
animals in test group were treated with A. Aspera 
ethanolic extract (400 mg/ kg i.p.) respectively. 
Each animal was treated with respective drug 30 
min before experimentation. Following are the 
etails of experiments performed,          d
  
Tail Flick Response Method 
The activity was screened according to 
previously reported method with minor 
modifications [13]. Prescreened animals (reaction 
time: 3-5sec) were used to assess the tail flick 
latency by the analgesiometer. A cut off period of 
15 secs was observed to avoid damage to the tail. 
The reaction time was recorded at 30, 60, 90, 120 
and 180 min after the administration of drugs. 
 
Hot Plate Method 
The test is performed using Eddy’s hot plate 
maintained at a temperature of 55 ± 1°C. 
Prescreened animals (reaction time: 3-5sec) were 
used to assess the reaction time at 30, 60, 90, 120 
and 180 min after the administration of drugs. A 
cut off period of 10 secs is observed to avoid 
damage to the paws [14].    
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Formalin Test 
20 microgram of 2.5% formalin solution was 
injected subcutaneously under the surface of the 
right hind paw for the induction of pain. [15] 
Animals were treated with respective drugs 1hr 
before the formalin injection. Immediately after 
the formalin injection the time of pain reactions 
were registered that the animals remained licking 
or biting the paw during the first phase (0-5 min 
i.e. neurogenic) and the second phase (15-30 min 
i.e. inflammatory) of the test. Percent inhibitions 
of time pain reactions were calculated by the 
formula:  
                        % Inhibition =(C-T)/C × 100 
where C and T indicate non-treated (vehicle) and 
drug-treated, respectively. [16]    
                                                                                                                                                         
Statistical Analysis 
 For thermal tests data was analyzed by ANOVA 
test followed by Dunnett’s test.  All the results 
were expressed as Mean (±SEM). P <0.05 was 
considered significant. 
 
Results     
Phytochemical screening 
 Phytochemical screening of ethanol extract 
revealed presence of triterpenoid saponins (A & 
B) possessing oleanolic acid as aglycone, 
alkaloid achyranthine, water soluble base betaine 
and steroids, while flavonoids and tannins were 
found absent. 
Acute toxicity study 
The results of acute toxicity study showed no 
clinical signs of toxicity and mortality in the 
A.Aspera treated animals. Lethal dose was 
calculated and was found to be more than 2000 
mg/kg. 1/5th of this lethal dose (400 mg/kg) was 
taken as effective dose for the study since 1/10th 
of lethal dose showed no activity in our earlier 
study. [17] 
Tail Flick Response and Hot Plate Method 
Pentazocine (10mg/kg) and A.Aspera leaf extract 
(400mg/kg) treated groups showed significant 
analgesic activity at 30, 60, 90 and 120min when 
compared to control. (Table-1, Table- 2). 
 
 
Table 1:  Mean reaction time in hot plate method (cut off time 10 secs.) 
 
 
 n=6, The percent inhibition for each group was calculated by comparison with the control group.  
    Values indicate Mean ± S.E.M. (ANOVA test followed by Dunnett’s t-test). Significance variation 
against control at, *p <0.001. 
 
 
 
 
 
 
 
 
 
 
 
Mean reaction time (in secs.) ± SEM Groups (n=6 ) Dose  Basal 30 mins 60 mins 90 mins 120mins 180 mins 
Control 5% gum acacia 3.5±0.22 3.3±0.21 3.5±0.57 3.5±0.57 3.7±0.33 3.5±0.42 
Standard  
(Pentazocine) 10mg/kg 3.7±0.33 7.7±0.66* 7.5±0.42* 7.5±0.42* 4.8±0.30* 3.3±0.21 
Test II 
(A.Aspera 
extract) 
400 mg/kg 3.3±0.42 8.0±0.57* 7.3±0.49* 7.3±0.49* 4.8±0.30* 3.2±0.17 
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Table 2: Tail flick latency in tail flick method (cut off time 15 secs.) 
 
 
 
 
 
 
 
 
 
 
 n=6, The percent inhibition for each group was calculated by comparison with the control group. 
Values indicate Mean ± S.E.M.(ANOVA test followed by Dunnett’s t-test). Significance variation 
against control at, *p<0.01, ** p<0.001. 
 
 
Table-3: Observation table for formalin paw licking method: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percent inhibitions of time pain reactions were calculated by the formula:   (C-T)/C × 100 (%), where 
C and T indicate non-treated (vehicle) and drug-treated, respectively.   
 
  
Formalin Test 
Extract (400 mg/kg i.p.) reduced the formalin 
induced pain in both phases (i.e. neurogenic and 
inflammatory) by 58.8% and 92.7%, respectively. 
(Table-3)          
                                     
Discussion 
Hot plate and tail flick tests model an acute 
thermal pain in mice. These are commonly used 
to assess narcotic analgesia, only the central 
analgesics increase the time of response in these 
tests. However chemical pain is inhibited by the 
both central and peripheral analgesics [18].  
The formalin test is believed to represent a more 
valid model for clinical pain. The formalin test is 
a very useful method, not only for assessing 
antinociceptive drugs, but also helping in the 
elucidation of the action mechanism. The 
neurogenic phase is probably a direct result of 
stimulation in the paw and reflects centrally 
mediated pain with release of substance P while 
the late phase is due to the release of histamine, 
serotonin, bradykinin and prostaglandins. Drugs 
that act primarily on the central nervous system, 
such as narcotics, inhibit both phases equally 
while peripherally acting drugs such as anti-
Mean value of Tail Flick Latency (sec)±S.E.M. Groups 
 
(n=6 ) 
Dose 
 
 Basal 30 mins 60 mins 90 mins 120mins 180 mins 
Control 5% gum acacia 3.7±0.33 3.3±0.42 3.3±0.42 3.5±0.34 3.7±0.33 3.8±0.30 
Standard  
(Pentazocine) 10mg/kg 3.5±0.34 12.2±1.37** 10.3±0.66** 8.2±0.61** 5.2±0.48** 3.7±0.33 
Test II 
( A. Aspera 
extract) 
400 mg/kg 2.7±0.33 8.7±1.58** 9.7±1.38** 7.3±0.61** 4.8±0.30* 3.0±0.26 
Mean  Licking time  in secs (% inhibition) 
Drugs 
(n=6 ) 
First phase  (0-5mins) Second phase (15-30mins ) 
Group-I  (5% gum acacia) 83.67 27.33 
Group-II  (Pentazocine10mg/kg) 7.3 (91.3%) 5.3 (80.6%) 
Group-III (Aspirin 100mg/kg) 32.7 (60.9%) 1.7 (93.8%) 
Group-IV ( A. Aspera extract 400 mg/kg) 34.5 (58.8%) 2.0 (92.7%) 
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inflammatory non-steroidal (NSAID) and anti-
inflammatory steroidal only inhibit the late phase. 
[18] EEAA was able to block both phases of the 
formalin response although the effect was more 
pronounced in the second phase. Observations of 
our study strongly suggest that EEAA possess 
centrally and peripherally mediated 
antinociceptive properties. 
 
The peripheral antinociceptive effect of EEAA 
may be mediated via inhibition of 
cycloxygenases and/or lipoxygenases (and other 
inflammatory mediators). Phytochemical 
screening of EEAA revealed presence of 
triterpenoid saponins possessing oleanolic acid as 
aglycone, alkaloid achyranthine and steroids. 
Achyranthine is reported to have anti-
inflammatory activity and it has similar 
mechanism of action as that of steroids i.e. by 
inhibiting prostaglandin synthesis at 
phospholipase A2 and at the level of cyclo-
oxygenase/PGE isomerase [19, 8] and 
triterpenoid oleanolic acid also reported to have 
inflammatory activity due to powerful inhibitory 
actions on cellular inflammatory processes such 
as the induction by IFN-γ of inducible nitric 
oxide synthase (iNOS) and of cyclooxygenase 2. 
[20, 21] Hence peripheral antinociceptive activity 
observed for EEAA may be due to presence of 
triterpenoid saponins, achyranthine and steroids 
in the extract. Anti-inflammatory drugs exhibit 
analgesic activity via inhibition of inflammatory 
mediators release responsible for inflammatory 
pain. 
 
For central antinociceptive action however 
aminergic and GABAergic receptors mediated 
mechanisms may be considered [18] Triterpenoid 
saponins are reported to have 
agonistic/facilitatory activities at these receptors 
[22, 23] and presence of these phytochemicals in 
EEAA said to exhibit central antinociceptive 
activity. 
 
Conclusion 
From the obtained results we can conclude that 
EEAA possesses considerable antinociceptive 
activity which is comparable with the standards. 
In vivo inhibition of pain in the thermal test 
indicates that EEAA exhibits central activity. 
Indeed, it was also observed in the formalin test 
that this extract exhibited a high peripheral 
antinociceptive activity. Triterpenoid saponins 
(central and peripheral), achyranthine and 
steroids (peripheral) may be the phytochemicals 
responsible for this antinociceptive activity. 
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